Product
Ezetimibe/Simvastatin + Niacin
1 clinical trial
1 indication
Indication
HypercholesterolemiaClinical trial
Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) Co-Administered in Patients With Type IIa or Type IIb HyperlipidemiaStatus: Completed, Estimated PCD: 2008-02-01